SpaMedica Launches Glaucoma Service

SpaMedica, the UK’s leading independent provider of NHS cataract surgery, is launching a glaucoma service across its network of specialist eye hospitals, where NHS patients will benefit from reduced waiting times for glaucoma assessments, monitoring and treatment.

The service is currently available at the following hospitals, with plans to expand to more sites throughout 2025:

  • SpaMedica Sale and SpaMedica Manchester – accepting referrals for patients living in Greater Manchester.
  • SpaMedica Worcester – accepting referrals for patients living in Worcestershire and Herefordshire
  • SpaMedica Chester and SpaMedica Haydock – accepting referrals for patients living in Cheshire and Merseyside

Offering a fast-track referral service, SpaMedica will follow treatment pathways recommended by the National Institute for Health and Care Excellence (NICE), including selective laser trabeculoplasty (SLT) as a first-line treatment for primary open angle glaucoma (POAG) where appropriate.

Patients will also remain under regular review once their condition is stable, ensuring continued oversight and care.

There are currently over 700,000 people living with glaucoma in the UK, and glaucoma accounts for around 20% of all outpatient appointments in hospital eye services. Between 2020-2035, the number of people living with glaucoma is expected to increase by almost a third, and healthcare professionals have expressed concern about whether the sector has sufficient resources to meet the increase in demand.

In a 2023 survey of UK optometrists, 72% said they had seen a patient who had experienced a delay to treatment of 12 months or more, while nearly half (43%) had concerns about patients needlessly losing their sight.

Claire Wood, Clinical Lead Optometrist (Glaucoma) at SpaMedica said: “It’s vital that NHS patients are able to access care when they need it and we know that, for conditions like glaucoma, time is of the essence and regular monitoring is essential. That’s why we’re proud to be working in close partnership with the NHS and community optometrists to ensure patients receive high-quality care, as quickly as possible.

“Our glaucoma service will be an all-in-one solution for many patients with primary open angle glaucoma – offering diagnostics, a variety of treatment options, and regular check-ups. We plan to bring the service to more hospitals soon and hope to see a significant improvement in the accessibility of glaucoma services across England as a result.”

To mark the launch of the service, SpaMedica will be holding a series of free CPD sessions for community optometrists, beginning with ‘Modern Approaches to Glaucoma Management: Innovation and Best Practice,’ presented by Neeru Vallabh, Consultant Ophthalmologist (Glaucoma) and Clinical Senior Lecturer – University of Liverpool. The evening event, worth one CPD point, will be held at SpaMedica’s Sale hospital on Old Hall Road on Wednesday 19th March, from 6pm-8.30pm, and will include a tour of the hospital. Those wishing to attend can register via the following link: https://www.eventbrite.co.uk/e/glaucoma-cpd-evening-sale-tickets-1263934144049.

Since opening in 2008, SpaMedica has earned a reputation for excellence, with industry regulator the Care Quality Commission awarding every SpaMedica hospital it has inspected to date a ‘Good’ or ‘Outstanding’ rating. 98% of patients who have reviewed SpaMedica on the NHS website have given the provider a five-star rating.

Optometrists wishing to refer their patients to SpaMedica’s glaucoma service should follow the referral pathway specified by their local ICB. To find out more visit www.spamedica.co.uk

About Lisa Baker, Editor, Wellbeing News 4936 Articles
Editor Lisa Baker is a professional writer and the owner of Need to See IT Publishing. However, Lisa is also passionate about the benefits of a holistic approach to healing, being a qualified Vibrational Therapist. Lisa also has qualifications in Auricular Therapy, Massage, Kinesiology, Crystal Healing, Seichem and is a Reiki Master.